Prescribing Information     Patient's Instructions for Use
Patients: remember to vigorously shake your COMBIVENT Inhalation Aerosol for 10 seconds before each use or inhalation.
INDICATIONS AND USAGE:

Combivent® (ipratropium bromide and albuterol sulfate) Inhalation Aerosol is indicated for use in patients with chronic obstructive pulmonary disease (COPD) on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.


Copyright © 2006, Boehringer Ingelheim Pharmaceuticals, Inc. All rights reserved. The use of and access to the information on this site is subject to the terms and conditions set out in the Agreement to use the Boehringer Ingelheim Corporation and its U.S. affiliates' Web sites.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch or call 1-800-FDA-1088.

Please review the Terms and Conditions and Privacy Statement. Product information contained in this site is intended for U.S. residents only. COMBIVENT is a registered trademark of Boehringer Ingelheim GmbH or its subsidiaries, affiliates or licensees.

See full Prescribing Information.
See Patient's Instructions for Use.